High blood pressure control and lipid lowering in patients at high cardiovascular risk: a cluster randomised factorial comparison of educational and protocol-based interventions to help primary care teams improve control of patients with poor risk factor control

Not Applicable

Completed

• Conditions: Topic: Cardiovascular, Diabetes Research Network, Primary Care Research Network for England; Subtopic: Both, Not Assigned, Cardiovascular (all Subtopics); Disease: Diabetic Control, Cardiovascular, All Diseases; Circulatory System; High cardiovascular risk

• Registration Number: ISRCTN99472145
• Lead Sponsor: William Harvey Research Institute (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06-18
• Last Update Posted: 8 May 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

1. Elevated systolic blood pressure greater than or equal to 160 mmHg within the last 12 months
2. Elevated total cholesterol greater than or equal to 5 mmol/l
3. Patients in secondary prevention, or risk equivalent, or hypertensives in primary prevention at more than 20% 10-year cardiovascular disease (CVD) risk by QRISK2 or Framingham equations
4. Male and female, lower age limit of 40 years

Exclusion Criteria

Compelling reasons to avoid increase in blood pressure or lipid-lowering medication, such as severe debilitating illness or terminal cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in blood pressure (BP) treatment at 1 year

Secondary Outcome Measures

Name	Time	Method
1. Change in lipid treatment at 1 year<br>2. Change in systolic blood pressure (BP) at 1 year<br>3. Change in total cholesterol at 1 year